MSGID: 1:317/3 64718770
PID: hpt/lnx 1.9.0-cur 2019-01-08
TID: hpt/lnx 1.9.0-cur 2019-01-08
 Protein-based nano-'computer' evolves in ability to influence cell
behavior 

  Date:
      May 26, 2023
  Source:
      Penn State
  Summary:
      The first protein-based nano-computing agent that functions as a
      circuit has been created. The milestone puts them one step closer
      to developing next-generation cell-based therapies to treat diseases
      like diabetes and cancer.


      Facebook Twitter Pinterest LinkedIN Email

==========================================================================
FULL STORY
==========================================================================
The first protein-based nano-computing agent that functions as a circuit
has been created by Penn State researchers. The milestone puts them one
step closer to developing next-generation cell-based therapies to treat
diseases like diabetes and cancer.

Traditional synthetic biology approaches for cell-based therapies, such
as ones that destroy cancer cells or encourage tissue regeneration after
injury, rely on the expression or suppression of proteins that produce a
desired action within a cell. This approach can take time (for proteins
to be expressed and degrade) and cost cellular energy in the process. A
team of Penn State College of Medicine and Huck Institutes of the Life
Sciences researchers are taking a different approach.

"We're engineering proteins that directly produce a desired action,"
said Nikolay Dokholyan, G. Thomas Passananti Professor and vice chair
for research in the Department of Pharmacology. "Our protein-based
devices or nano-computing agents respond directly to stimuli (inputs)
and then produce a desired action (outputs)."  In a study published in
Science Advances today (May 26) Dokholyan and bioinformatics and genomics
doctoral student Jiaxing Chen describe their approach to creating their
nano-computing agent. They engineered a target protein by integrating
two sensor domains, or areas that respond to stimuli. In this case,
the target protein responds to light and a drug called rapamycin by
adjusting its orientation, or position in space.

To test their design, the team introduced their engineered protein into
live cells in culture. By exposing the cultured cells to the stimuli,
they used equipment to measure changes in cellular orientation after
cells were exposed to the sensor domains' stimuli.

Previously, their nano-computing agent required two inputs to produce
one output. Now, Chen says there are two possible outputs and the
output depends on which order the inputs are received. If rapamycin is
detected first, followed by light, the cell will adopt one angle of cell
orientation, but if the stimuli are received in a reverse order, then the
cell adopts a different orientation angle. Chen says this experimental
proof-of-concept opens the door for the development of more complex
nano-computing agents.

"Theoretically, the more inputs you embed into a nano-computing agent, the
more potential outcomes that could result from different combinations,"
Chen said.

"Potential inputs could include physical or chemical stimuli and outputs
could include changes in cellular behaviors, such as cell direction,
migration, modifying gene expression and immune cell cytotoxicity
against cancer cells."  The team plans to further develop their
nano-computing agents and experiment with different applications of the
technology. Dokholyan, a researcher with Penn State Cancer Institute
and Penn State Neuroscience Institute, said their concept could someday
form the basis of the next-generation cell-based therapies for various
diseases, such as autoimmune diseases, viral infections, diabetes,
nerve injury and cancer.

Yashavantha Vishweshwaraiah, Richard Mailman and Erdem Tabdanov of Penn
State College of Medicine also contributed to this research. The authors
declare no conflicts of interest.

This work was funded by the National Institutes of Health (grant
1R35GM134864) and the Passan Foundation.

    * RELATED_TOPICS
          o Health_&_Medicine
                # Stem_Cells # Lung_Cancer # Lymphoma
          o Plants_&_Animals
                # Cell_Biology # Molecular_Biology #
                Biotechnology_and_Bioengineering
          o Matter_&_Energy
                # Biochemistry # Batteries # Organic_Chemistry
          o Computers_&_Math
                # Computer_Science # Mobile_Computing #
                Spintronics_Research
    * RELATED_TERMS
          o Blood_transfusion o Stem_cell_treatments o Stem_cell o
          Chemotherapy o Gene_therapy o Nutrition o Personalized_medicine
          o Circuit_design

==========================================================================
Story Source: Materials provided by Penn_State. Original written by
Zachary Sweger. Note: Content may be edited for style and length.


==========================================================================
Journal Reference:
   1. Jiaxing Chen, Yashavantha L. Vishweshwaraiah, Richard B. Mailman,
   Erdem
      D. Tabdanov, Nikolay V. Dokholyan. A noncommutative
      combinatorial protein logic circuit controls cell orientation
      in nanoenvironments. Science Advances, 2023; 9 (21) DOI:
      10.1126/sciadv.adg1062
==========================================================================

Link to news story:
https://www.sciencedaily.com/releases/2023/05/230526142234.htm

--- up 1 year, 12 weeks, 4 days, 10 hours, 50 minutes
 * Origin: -=> Castle Rock BBS <=- Now Husky HPT Powered! (1:317/3)
SEEN-BY: 15/0 106/201 114/705 123/120 153/7715 218/700 226/30 227/114
SEEN-BY: 229/110 112 113 307 317 400 426 428 470 664 700 291/111 292/854
SEEN-BY: 298/25 305/3 317/3 320/219 396/45
PATH: 317/3 229/426